Chk1 promotes replication fork progression by controlling replication initiation.
DNA replication starts at initiation sites termed replication origins. Metazoan cells contain many more potential origins than are activated (fired) during each S phase. Origin activation is controlled by the ATR checkpoint kinase and its downstream effector kinase Chk1, which suppresses origin firing in response to replication blocks and during normal S phase by inhibiting the cyclin-dependent kinase Cdk2. In addition to increased origin activation, cells deficient in Chk1 activity display reduced rates of replication fork progression. Here we investigate the causal relationship between increased origin firing and reduced replication fork progression. We use the Cdk inhibitor roscovitine or RNAi depletion of Cdc7 to inhibit origin firing in Chk1-inhibited or RNAi-depleted cells. We report that Cdk inhibition and depletion of Cdc7 can alleviate the slow replication fork speeds in Chk1-deficient cells. Our data suggest that increased replication initiation leads to slow replication fork progression and that Chk1 promotes replication fork progression during normal S phase by controlling replication origin activity.
Petermann
Eva
E
Gray Institute for Radiation Oncology and Biology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, United Kingdom. e.petermann@bham.ac.uk
Woodcock
Mick
M
Helleday
Thomas
T
D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D000071877:Checkpoint Kinase 1; D004247:DNA / Q000235:genetics*; D004261:DNA Replication; D006801:Humans; D011494:Protein Kinases / Q000235:genetics / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D034622:RNA Interference; D016196:S Phase
D018797:Cell Cycle Proteins; D004247:DNA; D011494:Protein Kinases; C068619:CDC7 protein, human; C000605867:CHEK1 protein, human; D000071877:Checkpoint Kinase 1; D017346:Protein Serine-Threonine Kinases
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8956-61
18579778
Nat Chem Biol. 2008 Jun;4(6):357-65
18469809
Curr Opin Cell Biol. 2006 Jun;18(3):231-9
16650748
Cell Cycle. 2003 Jul-Aug;2(4):316-24
12851482
Cell Cycle. 2004 Jul;3(7):941-5
15190204
Mol Cell Biol. 2004 Aug;24(16):7140-50
15282313
Cell. 2003 Aug 8;114(3):385-94
12914702
J Biol Chem. 2007 Mar 30;282(13):9458-9468
17276990
Nature. 2001 Apr 12;410(6830):842-7
11298456
J Cell Biol. 1998 Mar 23;140(6):1285-95
9508763
Oncogene. 2008 May 29;27(24):3475-82
18084324
Mol Cell. 2010 Feb 26;37(4):492-502
20188668
Cancer Res. 2004 Oct 1;64(19):7110-6
15466207
Mol Biol Cell. 2008 Jun;19(6):2373-8
18353973
Cancer Res. 2005 Feb 1;65(3):780-6
15705874
Mol Cell Biol. 2002 Dec;22(24):8552-61
12446774
J Biol Chem. 2005 Sep 2;280(35):31208-19
15975926
J Biol Chem. 2007 Jan 5;282(1):208-15
17062569
Science. 2003 Jun 6;300(5625):1542-8
12791985
Nat Cell Biol. 2004 Jul;6(7):648-55
15220931
Genes Dev. 2000 Jun 15;14(12):1448-59
10859164
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20752-7
19091954
EMBO J. 2008 Mar 19;27(6):876-85
18309293
Eur J Biochem. 1997 Jan 15;243(1-2):527-36
9030781
EMBO J. 2003 Feb 3;22(3):713-23
12554671
Science. 2007 Dec 21;318(5858):1928-31
18096807
Chromosoma. 2007 Aug;116(4):341-7
17404750
Mol Cell. 2003 Apr;11(4):1109-17
12718895
Nature. 2008 Sep 25;455(7212):557-60
18716622
Genes Dev. 2007 Dec 15;21(24):3331-41
18079179
Mol Cell Biol. 2006 Apr;26(8):3319-26
16581803
J Cell Biol. 2001 Sep 3;154(5):913-23
11535615
Mol Cell Biol. 2001 Jul;21(13):4129-39
11390642
Genes Dev. 2000 Nov 1;14(21):2745-56
11069891
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14795-800
12399544
J Biol Chem. 2003 Feb 7;278(6):4295-304
12424256
Eur J Cancer. 2010 Jan;46(1):33-40
19815406
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14320-5
9405610
EMBO J. 2007 Jun 6;26(11):2719-31
17491592
Mol Cell Biol. 2005 May;25(9):3553-62
15831461